XBiotech
XBIT
XBIT
50 hedge funds and large institutions have $37.5M invested in XBiotech in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 46 → 50 (+4)
1.1% more ownership
Funds ownership: 14.83% → 15.93% (+1.1%)
Holders
50
Holding in Top 10
–
Calls
$8K
Puts
$3K
Top Buyers
| 1 | +$896K | |
| 2 | +$813K | |
| 3 | +$415K | |
| 4 |
Morgan Stanley
New York
|
+$241K |
| 5 |
Goldman Sachs
New York
|
+$211K |
Top Sellers
| 1 | -$623K | |
| 2 | -$155K | |
| 3 | -$105K | |
| 4 |
AGM
Alpine Global Management
New York
|
-$91.5K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$66.4K |